However, as serum AFP is also related to the altered hepatocyte architectures in CHC[32], rapid normalization of serum AFP after IFN-free DAAs could be misleading; cautious re-evaluation of this useful clinical tumor marker is needed. This evidence concerns the gene AFP and cryohydrocytosis.